נורמיטן 100 ישראל - עברית - Ministry of Health

נורמיטן 100

teva pharmaceutical industries ltd, israel - atenolol - טבליה - atenolol 100 mg - atenolol - atenolol - management of angina pectoris and hypertension,including hypertension of renal origin. late intervention after acute myocardial infarction.

פרבסטאטין טבע 10 מג ישראל - עברית - Ministry of Health

פרבסטאטין טבע 10 מג

teva pharmaceutical industries ltd, israel - pravastatin sodium - טבליה - pravastatin sodium 10 mg - pravastatin - pravastatin - pravastatin is indicated as a component of multiple risk factor intervention in those individuals at increased risk for atherosclerotic vascular disease due to hypercholesterolemia . pravastatin should be used in addition to a diet restricted in saturated fat and cholesterol when the response to diet and other nonpharmacological measures alone has been inadequate. *primary prevention of coronary events: in hypercholesterolemic patients whthout clinically evident coronary heart disease pravastatin is indicated to: - reduce the risk of myocardial infarcton. - reduce the risk for revascularization. - reduce the risk of deaths due to cardiovascular causes with no increase in deaths from non-cardiovascular causes. *secondary prevention of cardiovascular events: atherosclerosis: in hypercholesterolemic patients with clinically evident coronary artery disease including prior mi pravastatin is indicated to: - slow the progression of coronary atherosclerosis. - reduce the risk of acute coronary events. myocardial infa

פרבסטאטין טבע 20 מג ישראל - עברית - Ministry of Health

פרבסטאטין טבע 20 מג

teva pharmaceutical industries ltd, israel - pravastatin sodium - טבליה - pravastatin sodium 20 mg - pravastatin - pravastatin - pravastatin is indicated as a component of multiple risk factor intervention in those individuals at increased risk for atherosclerotic vascular disease due to hypercholesterolemia . pravastatin should be used in addition to a diet restricted in saturated fat and cholesterol when the response to diet and other nonpharmacological measures alone has been inadequate. *primary prevention of coronary events: in hypercholesterolemic patients whthout clinically evident coronary heart disease pravastatin is indicated to: - reduce the risk of myocardial infarcton. - reduce the risk for revascularization. - reduce the risk of deaths due to cardiovascular causes with no increase in deaths from non-cardiovascular causes. *secondary prevention of cardiovascular events: atherosclerosis: in hypercholesterolemic patients with clinically evident coronary artery disease including prior mi pravastatin is indicated to: - slow the progression of coronary atherosclerosis. - reduce the risk of acute coronary events. myocardial infa

פרדניזון 20 מג ישראל - עברית - Ministry of Health

פרדניזון 20 מג

rekah pharmaceutical industry ltd, israel - prednisone - טבליה - prednisone 20 mg - prednisone - prednisone - anti-inflammatory for treatment of inflammation responsive to glucocorticosteroids such as: acute allergies, rheumataid arthritis.

מטרוג'יל ישראל - עברית - Ministry of Health

מטרוג'יל

teva pharmaceutical indust.ltd - metronidazole 250 mg - tablets - metronidazole - for the treatment of : - symptomatic trichomoniasis in women and men when the presence of the trichomonad has been confirmed by appropriate laboratory procedures. - asymptomatic trichomoniasis in women when the organism is associated with endocervicitis cervicitis or cervical erosion. - asymptomatic consort. - acute intestinal amebiasis (amebic dysentery) and amebic liver absess. - anaerobic bacterial infections caused by susceptible anaerobic bacteria.

ארטופן 400 מג ישראל - עברית - Ministry of Health

ארטופן 400 מג

teva pharmaceutical industries ltd, israel - ibuprofen - טבליה - ibuprofen 400 mg - ibuprofen - ibuprofen - for the treatment of rheumatoid arthritis and osteoarthritis, it is indicated both in the treatment of acute flares and in the longterm management of these diseases. for the relief of mild to moderate pain and for the treatment of primary dysmenorrhea.

נקסין פתילות ישראל - עברית - Ministry of Health

נקסין פתילות

teva pharmaceutical indust.ltd - naproxen 500 mg - suppositories - naproxen - - rheumatic disease-antiinflammatory. - periarticular and musculoskeletal disorders. - acute gouty arthritis. - primary dysmenorrhea.

איזי ג'ל ישראל - עברית - Ministry of Health

איזי ג'ל

teva pharmaceutical indust.ltd - benzydamine hydrochloride 5 % - gel - benzydamine - local acute inflammatory disorders.

מוסקול ישראל - עברית - Ministry of Health

מוסקול

teva pharmaceutical industries ltd, israel - orphenadrine (citrate); paracetamol - טבליה - paracetamol 500 mg; orphenadrine (citrate) 30 mg - orphenadrine, combinations - orphenadrine, combinations - relief of mild to moderate pain of acute musculoskeletal disorders.

טופיראמט טבע   25 מג ישראל - עברית - Ministry of Health

טופיראמט טבע 25 מג

teva pharmaceutical industries ltd, israel - topiramate - טבליה - topiramate 25 mg - topiramate - topiramate - topiramate teva is indicated as adjunctive therapy for adults and children aged 6 and above with partial onset seizures or generalized tonic-clonic seizures. topiramate teva is also indicated in adults and children as adjunctive therapy for the treatment of seizures associated with lennox-gastaut syndrome . topiramate teva is indicated as monotherapy in patients with newly diagnosed epilepsy in adults and children aged 7 years and above or for conversion to monotherapy in patients with epilepsy.topiramate teva is indicated in adults for the prevention of migraines. the use of topiramate teva in the acute treatment of migraine has not been studied .